Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-354145

Corbus Pharmaceuticals Holdings, Inc. · CRBP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Leonardo Viana Nicacio
Officer — Chief Medical Officer
Period of report
Aug 16, 2026
Accepted (ET)
Aug 17, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001595097

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001 per shareF1,F2Aug 16, 2026A58,333$0.00A58,333D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock options (right to buy)F3$10.09Aug 16, 2026A191,676A—Aug 16, 2036Common Stock191,676191,676D

Explanation of responses